During the past decade, St. Antonius Ziekenhuis conducted 269 clinical trials. In the 10-year time frame, 269 clinical trials started and 78 clinical trials were completed, i.e. on average, 29% percent of trials that started reached the finish line to date. In the past 5 years, 121 clinical trials started and 41 clinical trials were completed. i.e. 33.9% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Antonius Ziekenhuis" #1 sponsor was "St. Antonius Hospital" with 65 trials, followed by "Abbott Medical Devices" with 18 trials sponsored, "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 18 trials sponsored, "Radboud University Medical Center" with 18 trials sponsored and "Boston Scientific Corporation" with 18 trials sponsored. Other sponsors include 322 different institutions and companies that sponsored additional 163 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Antonius Ziekenhuis" #1 collaborator was "ZonMw: The Netherlands Organisation for Health Research and Development" with 27 trials as a collaborator, "St. Antonius Hospital" with 19 trials as a collaborator, "Erasmus Medical Center" with 9 trials as a collaborator, "UMC Utrecht" with 9 trials as a collaborator and "Amsterdam UMC, location VUmc" with 8 trials as a collaborator. Other collaborators include 360 different institutions and companies that were collaborators in the rest 264 trials.

According to Clinical.Site data, the most researched conditions in "St. Antonius Ziekenhuis" are "Atrial Fibrillation" (28 trials), "Coronary Artery Disease" (25 trials), "Heart Failure" (13 trials), "Stroke" (12 trials) and "Breast Cancer" (9 trials). Many other conditions were trialed in "St. Antonius Ziekenhuis" in a lesser frequency.

Most popular intervention types in "St. Antonius Ziekenhuis" are "Drug" (181 trials), "Device" (165 trials), "Procedure" (74 trials), "Other" (35 trials) and "Biological" (16 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (35 trials), "cisplatin" (7 trials), "Docetaxel" (6 trials), "Bevacizumab" (5 trials) and "Clopidogrel" (5 trials). Other intervention names were less common.

The vast majority of trials in "St. Antonius Ziekenhuis" are 424 trials for "All" genders, 23 trials for "Female" genders and 16 trials for "Male" genders.

Currently, there are 159 active trials in "St. Antonius Ziekenhuis". 7 are not yet recruiting, 93 are recruiting, 53 are Active, not recruiting, and 6 are Enrolling by invitation. In total, there were 216 completed trials in St. Antonius Ziekenhuis, 1 suspended trials, and 46 terminated clinical trials to date.

Out of the total trials that were conducted in St. Antonius Ziekenhuis, 6 "Phase 1" clinical trials were conducted, 50 "Phase 2" clinical trials and 109 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 57 trials, and there were also 159 trials that are defined as “Not Applicable".

St. Antonius Ziekenhuis has several departments that took part in Clinical trials: "Antonius Ziekenhuis; Dept of Lung Diseases" - 4 trials